Sepsis

Companies Sepsis

News Sepsis

• Analytik Jena to develop products for sepsis diagnostics

  Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik Jena AG, more

• Diagnostics Company SIRS-Lab insolvent

  SIRS-Lab requested the opening of insolvency proceedings. The company, founded ten years ago, develops molecular diagnostic technologies for life-threatening infections as sepsis, also known as blood poisoning. Sepsis claims 250.000 victims per year in the USA alone. Therefore SIRS-Lab has developed more

• Lilly Announces Withdrawal of Xigris Following Recent Clinical Trial Results

  Eli Lilly and Company announced withdrawal of its Xigris® [drotrecogin alfa (activated)] product in all markets following results of the PROWESS-SHOCK study, which showed the study did not meet the primary endpoint of a statistically significant reduction in 28-day all-cause mortality in patients wi more

Publications Sepsis

• NOD2-mediated Suppression of CD55 on Neutrophils Enhances C5a Generation During Polymicrobial Sepsis

  by Sae Jin Oh, Ji Hyung Kim, Doo Hyun Chung Nucleotide-binding oligomerization domain (NOD) 2 is a cytosolic protein that plays a defensive role in bacterial infection by sensing peptidoglycans. C5a, which has harmful effects in sepsis, interacts with innate proteins. However, whether NOD2 regula more

• Volatile Metabolites of Pathogens: A Systematic Review

  by Lieuwe D. J. Bos, Peter J. Sterk, Marcus J. Schultz Ideally, invading bacteria are detected as early as possible in critically ill patients: the strain of morbific pathogens is identified rapidly, and antimicrobial sensitivity is known well before the start of new antimicrobial therapy. Bacter more

• Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009–2010 in Spain

  Background The present report compares prognosis in hospitalized cases with the H1N1 pandemic virus in two seasons. Methods Two series of hospitalized patients with laboratory‐confirmed H1N1 pandemic influenza have been compared: 813 in the season 2009–2010 and 707 in the season 2010–2011 more

Market studies Sepsis

• Sepsis – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Sepsis - Pipeline Review, H1 2012', provides an overview of the Sepsis therapeutic pipeline. This report provides information on the therapeutic development for Sepsis, complete with latest updates, and special features on late-stage and discontinued projects more

• Sepsis Global Clinical Trials Review, Q2, 2011

  Introduction GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, Q2, 2011" provides data on the Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sepsis. It includes an overview of the trial numbers and thei more

• Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Sepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Sepsis Therapeutics market. The report identifies the key tre more

Websites Sepsis